Skip to content
ClinCalc Pro
Menu
Anticonvulsant / Neuropathic Analgesic

Gabapentin

Brand names: Neurontin

Gabapentin is an antiepileptic and neuropathic-pain agent used for neuropathic pain and as adjunctive seizure therapy; in older people sedation, falls and renal dosing are central concerns.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It binds the alpha-2-delta subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release and modulating neuronal excitability.

Prescribing in practice

  • It is renally cleared, so reduce the dose in renal impairment common in older people, and titrate slowly to limit dizziness, sedation and falls.
  • Gabapentin is a controlled drug with potential for misuse and dependence; the combination with opioids increases the risk of respiratory depression and sedation.
  • Withdraw gradually to avoid withdrawal symptoms and, in epilepsy, the risk of rebound seizures.

Monitoring

Monitor for sedation, dizziness, mood changes and falls, and review renal function as a guide to dosing.

Counselling the patient

  • Drowsiness and dizziness are common at first; take care with driving and avoid falls.
  • Do not stop suddenly, as this can cause withdrawal effects.
  • Tell your team about opioid painkillers, as the combination can dangerously slow breathing.

Evidence & guidelines

MHRA guidance reclassified gabapentin as a controlled drug and warns of respiratory depression with concomitant opioids or in those with reduced respiratory reserve, including older patients.

Reference: NICE CG173 (Neuropathic Pain); MHRA Drug Safety Update 2017; AGS Beers Criteria 2023; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.